StemCell Institute Company Description

StemCell Institute Inc. engages in the stem cell banking business in Japan.

The company is also involved in research and development of new cell-based treatments, and pharmaceuticals and medical devices.

It also engages in cell contract management and transportation business; extraction, purification, processing, storage, testing and sales of biological tissue-derived components; and medical facility operation and management business.

StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.

StemCell Institute Inc.

Country	Japan
Founded	1999
Industry	Biotechnology
Sector	Healthcare
Employees	117
CEO	Takafumi Shimizu

Contact Details

Address: 1-21-19, Toranomon Tokyo, 105-0001 Japan
Phone	81 3 6811 3230
Website	stemcell.co.jp

Stock Details

Ticker Symbol	7096
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3399640006
SIC Code	8090

Key Executives

Name	Position
Takafumi Shimizu	Chief Executive Officer